Sensyne Health plc signed a non-exclusive agreement with Jefferson Health to evaluate the clinical and commercial potential of Sensyne Health’s GDm-Health™ digital therapeutic in the Jefferson Health system. GDm-Health is a patient-clinician software system for the data-driven management of gestational diabetes mellitus. Under the terms of the agreement, Sensyne Health will collaborate with Jefferson Health’s Department of Obstetrics and Gynaecology on a 12-month multi-phase Clinical and Health Economic Evaluation of the GDm-Health™ product in the Jefferson Health System Hospitals in Pennsylvania and New Jersey. Sensyne Health will have the right to analyse, using its proprietary clinical AI technology, the anonymised and de-identified patient data generated during the evaluation to help uncover new insights and address areas of unmet medical need in women’s health.